News

Afrezza is an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind’s to-be-marketed next-generation inhaler. MannKind chairman and chief executive officer Alfred Mann said the completion of the

The new operation will be led by Klaus Rafeiner, who has technical experience in software for life science, particularly enterprise software used in biological and chemical research and

The collaboration targets the clinical activity and side-effect profile of the study drugs. The pancreatic cancer and breast cancer are the first target clinical indications under consideration. Immunovative

GSK discontinued the GSK2251052 trials due to the identification of microbiological findings of resistance in few patients in the Phase 2b trial designed to treat complicated urinary tract

The QPS Qualitix China Office will provide various knowledge-based contract research services including comprehensive clinical trial management and regulatory submission preparation The facility will also allow the company

Under the contract, for the first project, Telstar will manage the construction of a plant for the production of oral solids consisting of a four-story building of 32,000

The launch was based on the results from a 5-year longitudinal study, funded by the NIH, which demonstrated the ability of the test in detecting Alzheimer’s disease at

Under the agreement, Dow will utilize its fundamental materials design, high-throughput screening, and pilot-plant, and commercial scale-up capabilities, while Bend will use its SDD screening, formulation, scale-up, and

The phase III studies data include VIKING-3 and SAILING studies, which used dolutegravir in treatment of HIV patients who have already experienced treatment. The two studies support the